BLACKSHEEP SCIENCES LIMITED

Active Royston
7 employees website.com
B

BLACKSHEEP SCIENCES LIMITED

Founded 25 Jul 2023 Active Royston, England 7 employees website.com

Previous Company Names

BLACKSHEEP POWER LIMITED 25 Jul 2023 — 1 Apr 2025
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 26 Jul 2025 Next due 7 Aug 2026 3 months remaining
Net assets £-1M £876K 2024 year on year
Total assets £82K £6K 2024 year on year
Total Liabilities £1M £882K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

27 Jarman Way Royston Hertfordshire SG8 5HW England

Website

www.example.com

Full company profile for BLACKSHEEP SCIENCES LIMITED (15028018), an active company based in Royston, England. Incorporated 25 Jul 2023. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£15.56k

Decreased by £12.53k (-45%)

Net Assets

-£1.11M

Decreased by £875.76k (-371%)

Total Liabilities

£1.19M

Increased by £882.05k (+283%)

Turnover

N/A

Employees

7

Increased by 1 (+17%)

Debt Ratio

1448%

Increased by 1038 (+253%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Andrew LovattDirectorBritishEngland541 Oct 2024Active
Mark Peter Timothy GilliganDirectorBritishEngland5525 Jul 2023Active

Shareholders

Shareholders (1)

Mark Peter Timothy Gilligan
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Mark Peter Timothy Gilligan

British

Active
Notified 25 Jul 2023
Residence England
DOB October 1970
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
27-29 Jarman Way, Royston (SG8 5HW) NORTH HERTFORDSHIRE
Leasehold-13 Mar 2024
27-29 Jarman Way, Royston (SG8 5HW)
Leasehold
Added 13 Mar 2024
District NORTH HERTFORDSHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
26 Jul 2025Confirmation StatementConfirmation statement made on 24 Jul 2025 with no updates
1 Apr 2025Change Of NameCertificate Change Of Name Company
5 Dec 2024AccountsAnnual accounts made up to 31 Mar 2024
14 Oct 2024OfficersAppointment of Dr Andrew Lovatt as director on 1 Oct 2024
18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

26 Jul 2025 Confirmation Statement

Confirmation statement made on 24 Jul 2025 with no updates

1 Apr 2025 Change Of Name

Certificate Change Of Name Company

5 Dec 2024 Accounts

Annual accounts made up to 31 Mar 2024

14 Oct 2024 Officers

Appointment of Dr Andrew Lovatt as director on 1 Oct 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

4 months ago on 18 Dec 2025

Confirmation statement made on 24 Jul 2025 with no updates

9 months ago on 26 Jul 2025

Certificate Change Of Name Company

1 years ago on 1 Apr 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 5 Dec 2024

Appointment of Dr Andrew Lovatt as director on 1 Oct 2024

1 years ago on 14 Oct 2024